Eli Lilly Surges 300% Since GLP-1 Approval, Now World's Most Valuable Pharma
Macro·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.
The company's remarkable growth highlights its significant impact on the pharmaceutical industry and investor confidence in its future prospects.
Eli Lilly
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.”
Bloomberg — Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning